Screening compound: C21H18BrN5O2 (S354-0576)

Screening compound: C<sub>21</sub>H<sub>18</sub>BrN<sub>5</sub>O<sub>2</sub> (S354-0576)
Screening compound: C<sub>21</sub>H<sub>18</sub>BrN<sub>5</sub>O<sub>2</sub> (S354-0576) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C21H18BrN5O2 (S354-0576)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S354-0576

Molecular Formula

C21H18BrN5O2 (C21 H18 BrN5 O2)

Compound Name

3-(3-bromophenyl)-5-[6-(2,4-dimethylphenyl)-4H,6H,7H-[1,2,3]triazolo[4,3-c][1,4]oxazin-3-yl]-1,2,4-oxadiazole

IUPAC name

3-(3-bromophenyl)-5-[6-(24-dimethylphenyl)-4H6H7H-[123]triazolo[43-c][14]oxazin-3-yl]-124-oxadiazole

SMILES

Cc1cc(C)c(C2OCc3c(-c4nc(-c5cccc(Br)c5)no4)nnn3C2)cc1

InChI

InChI=1S/C21H18BrN5O2/c1-12-6-7-16(13(2)8-12)18-10-27-17(11-28-18)19(24-26-27)21-23-20(25-29-21)14-4-3-5-15(22)9-14/h3-9,18H,10-11H2,1-2H3/t18-/m1/s1

InChI Key

ZDFMLGMORSXQLQ-GOSISDBHSA-N

MDL Number (MFCD)

MFCD29000579

C21H18BrN5O2 (S354-0576) in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Antiviral Library (67538 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
  • GPCR
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C21H18BrN5O2 (S354-0576) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C21H18BrN5O2 (S354-0576)?
Check Price and Availability of C21H18BrN5O2 (S354-0576), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C21H18BrN5O2 (S354-0576) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C21H18BrN5O2 (S354-0576)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C21H18BrN5O2 (S354-0576)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C21H18BrN5O2 (S354-0576) available by request